Toll-like receptor 2 participates in mediation of immune response in experimental pneumococcal meningitis

Journal of Immunology

Volumn 170, Issue 1, 2003, Pages 438-444

  Koedel, Uwe ^a   Angele, Barbara ^a   Rupprecht, Tobias ^a   Wagner, Hermann ^c   Roggenkamp, Andreas ^b   Pfister, Hans Walter ^a   Kirschning, Carsten J ^c  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN PROTEIN; COMPLEMENT COMPONENT C3; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 2; MESSENGER RNA; NITRIC OXIDE SYNTHASE; PEPTIDOGLYCAN; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL MENINGITIS; BODY WEIGHT; CHO CELL; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE COURSE; DISEASE SEVERITY; FIBROBLAST; GENE DISRUPTION; GENE OVEREXPRESSION; GENOTYPE; HOST; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNITY; MOLECULAR RECOGNITION; MOTOR DYSFUNCTION; MOUSE; MOUSE STRAIN; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR GENE; STREPTOCOCCUS INFECTION; SYMPTOM; TEMPERATURE;

EID: 0037220060     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.1.438     Document Type: Article

References (57)

1. Schuchat, A., K. Robinson, J. D. Wenger, L. H. Harrison, M. Farley, A. L. Reingold, L. Lefkowitz, and B. A. Perkins. 1997. Bacterial meningitis in the United States in 1995: Active surveillance team. N. Engl. J. Med. 337:970.
2. Durand, M. L., S. B. Calderwood, D. J. Weber, S. I. Miller, F. S. Southwick, V. S. Caviness, and M. N. Swartz. 1993. Acute bacterial meningitis in adults: A review of 493 episodes. N. Eugl. J. Med. 328:21.
3. Pfister, H. W., W. Feiden, and K. M. Einhäupl. 1993. Spectrum of complications during bacterial meningitis in adults. Arch. Neurol. 505:575.
4. Nathan, B. R., and W. M. Scheld. 2000. New advances in the pathogenesis and pathophysiology of bacterial meningitis. Curr. Infect. Dis. Rep. 2:332.
5. Braun, J. S., R. Novak, K.-H. Herzog, S. M. Bodner, J. L. Cleveland, and E. I. Tuomanen. 1999. Neuroprotection by a caspase inhibitor in acute bacterial meningitis. Nat. Med. 5:298.
6. Medzhitov, R., and C. A. J. Janeway. 1997. Innate immunity: The virtues of a nonclonal system of recognition. Cell 91:295.
7. Pugin, J., I. D. Heumann, A. Tomasz, V. V. Kravchenko, Y. Akamatsu, M. Nishijima, M. P. Glauser, P. S. Tobias, and R. J. Ulevitch. 1994. CD14 is a pattern recognition receptor. Immunity 1:509.
8. Cleveland, M. G., J. D. Gorham, T. L. Murphy, E. Tuomanen, and K. M. Murphy. 1996. Lipoteichoic acid preparations of Gram-positive bacteria induce interleukin-12 through a CD14-dependent pathway. Infect. Immun. 64:1906.
9. Dziarski, R., R. I. Tapping, and P. S. Tobias. 1998. Binding of bacterial peptidoglycan to CD14. J. Biol. Chem. 273:8680.
10. Landmann, R., B. Muller, and W. Zimmerli. 2000. CD14, new aspects of ligand and signal diversity. Microbes Infect. 2:295.
11. Akira, S. 2001. Toll-like receptors and innate immunity. Adv. Immunol. 78:1.
12. Medzhitov, R. 2001. Toll-like receptors and innate immunity. Nat. Rev. Immunol. 1:135.
13. Yoshimura, A., E. Lien, R. R. Ingalls, E. Tuomanen, R. Dziarski, and D. Golenbock. 1999. Cutting edge: Recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J. Immunol. 163:1.
14. Laflamme, N., G. Soucy, and S. Rivest. 2001. Circulating cell wall components derived from Gram-negative, not Gram-positive, bacteria cause a profound induction of the gene-encoding Toll-like receptor 2 in the CNS. J. Neurochem. 79:648.
15. Daum, R. S., D. W. Scheifele, V. P. Syriopoulou, D. Averill, and A. L. Smith. 1978. Ventricular involvement in experimental Hemophilus influenzae meningitis. J. Pediatr. 93:927.
16. Koedel, U., F. Winkler, B. Angele, A. Fontana, and H. W. Pfister. 2002. Meningitis-associated central nervous system complications are mediated by the activation of poly(ADP ribose) polymerase. J. Cereb. Blood Flow Metab. 22:39.
17. Koedel, U., F. Winkler, B. Angele, A. Fontana, R. A. Flavell, and H. W. Pfister. 2002. Role of caspase-1 in experimental pneumococcal meningitis: Evidence from pharmacologic caspase inhibition and caspase-1-deficient mice. Ann. Neurol. 51:319.
18. Fullerton, S. M., G. A. Shirman, W. J. Strittmatter, and W. D. Matthew. 2001. Impairment of the blood-nerve and blood-brain barriers in apolipoprotein e knockout mice. Exp. Neurol. 169:13.
19. Koedel, U., R. Paul, F. Winkler, S. Kastenbauer, P. L. Huang, and H. W. Pfister. 2001. Lack of endothelial nitric oxide synthase aggravates murine pneumococcal meningitis. J. Neuropathol. Exp. Neurol. 60:1041.
20. Werts, C., R. I. Tapping, J. C. Mathison, T. H. Chuang, V. Kravchenko, I. Saint Girons, D. A. Haake, P. J. Godowski, F. Hayashi, A. Ozinsky, et al. 2001. Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism. Nat. Immunol. 2:346.
21. Hornung, V., S. Rothenfusser. S. Britsch, A. Krug, B. Jahrsdorfer, T. Giese, S. Endres, and G. Hartmann. 2002. Quantitative expression of Toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J. Immunol. 168:4531.
22. Mambula, S. S., K. Sau, P. Henneke, D. T. Golenbock, and S. M. Levitz. 2002. Toll-like receptor (TLR) signaling in response to Aspergillus fumigatus. J. Biol. Chem. 277:39320.
23. Schindler, U., and V. R. Baichwal. 1994. Three NF-κB binding sites in the human E-selectin gene required for maximal tumor necrosis factor-α-induced expression. Mol. Cell. Biol. 14:5820.
24. Hirschfeld, M., C. J. Kirschning, R. Schwandner, H. Wesche, J. H. Weis, R. M. Wooten, and J. J. Weis. 1999. Cutting edge: Inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by Toll-like receptor 2. J. Immunol. 163:2382.
25. Du, X., A. Poltorak, Y. Wei, and B. Beutler. 2000. Three novel mammalian Toll-like receptors: Gene structure, expression, and evolution. Eur. Cytokine Network 11:362.
26. Bauer, S., C. J. Kirschning, H. Hacker, V. Redecke, S. Hausmann, S. Akira, H. Wagner, and G. B. Lipford. 2001. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc. Natl. Acad. Sci. USA 98:9237.
27. Alexopoulou, L., A. C. Holt, R. Medzhitov, and R. A. Flavell. 2001. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature 413:732.
28. Poltorak, A., X. He, I. Smirnova, M. Y. Liu, C. V. Huffel, X. Du, D. Birdwell, E. Alejos, M. Silva, C. Galanos, et al. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in TLR4 gene. Science 282:2085.
29. Qureshi, S. T., L. Lariviere, G. Leveque, S. Clermont, K. J. Moore, P. Gros, and D. Malo. 1999. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J. Exp. Med. 189:615.
30. Vabulas, R. M., S. Braedel, N. Hilf, H. Singh-Jasuja, S. Herter, P. Ahmad-Nejad, C. J. Kirschning, C. Da Costa, H. G. Rammensee, H. Wagner, and H. Schild. 2002. The endoplasmic reticulum-resident heat shock protein Gp96 activates dendritic cells via the Toll-like receptor 2/4 pathway. J. Biol. Chem. 277:20847.
31. Sande, M. A., and M. G. Tauber. 1999. Pneumococcal meningitis: Current pathophysiologic concepts. Microb. Drug Resist. 5:295.
32. Aderem, A., and R. J. Ulevitch. 2000. Toll-like receptors in the induction of the innate immune response. Nature 406:782.
33. Kirschning, C. J., and S. Bauer. 2001. Toll-like receptors: Cellular signal transducers for exogenous molecular patterns causing immune responses. Int. J. Med. Microbiol. 291:251.
34. Takeuchi, O., K. Hoshino, and S. Akira. 2000. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J. Immunol. 165:5392.
35. Wooten, R. M., Y. Ma, R. A. Yoder, J. P. Brown, J. H. Weis, J. F. Zachary, C. J. Kirschning, and J. J. Weis. 2002. Toll-like receptor 2 is required for innate, but not acquired, host defense to Borrelia burgdorferi. J. Immunol. 168:348.
36. Shimazu, R., S. Akashi, H. Ogata, Y. Nagai, K. Fukudorne, K. Miyake, and M. Kimoto. 1999. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med. 189:1777.
37. Giampaolo, C., W. M. Scheld, J. Boyd, J. Savory, M. A. Sande, and M. Wills. 1981. Leukocyte and bacterial interrelationships in experimental meningitis. Ann. Neurol. 9:328.
38. Täuber, M. G., S. L. Kennnedy, J. H. Tureen, and D. H. Lowenstein. 1992. Experimental pneumococcal meningitis causes central nervous system pathology without inducing the 72-kd heat shock protein. Am. J. Pathol. 141:53.
39. Tuomanen, E. I., K. Saukkonen, S. Sande, C. Cioffe, and S. D. Wright. 1989. Reduction of inflammation, tissue damage, and mortality in bacterial meningitis in rabbits treated with monoclonal antibodies against adhesion-promoting receptors of leukocytes. J. Exp. Med. 170:959.
40. Koedel, U., I. Bayerlein, R. Paul, B. Sporer, and H. W. Pfister. 2000. Pharmacological interference with NF-κB activation attenuates central nervous system complications in experimental pneumococcal meningitis. J. Infect. Dis. 182:1437.
41. Rubins, J. B., D. Charboneau, J. C. Paton, T. J. Mitchell, P. W. Andrew, and E. N. Janoff. 1995. Dual function of pneumolysin in the early pathogenesis of murine pneumococcal pneumonia. J. Clin. Invest. 95:142.
42. Zysk, G., B. K. Schneider-Wald, J. H. Hwang, L. Bejo, K. S. Kim, T. J. Mitchell, R. Hakenbeck, and H. P. Heinz. 2001. Pneumolysin is the main inducer of cytotoxicity to brain microvascular endothelial cells caused by Streptococcus pneumoniae. Infect. Immun. 69:845.
43. 2 mediate brain cell apoptosis during meningitis. J. Clin. Invest. 109:19.
44. Houldsworth, S., P. W. Andrew, and T. J. Mitchell. 1994. Pneumolysin stimulates production of tumor necrosis factor-α and interleukin-1β by human mononuclear phagocytes. Infect. Immun. 62:1501.
45. Valen, G., W. Erl, P. Eriksson, D. Wuttge, G. Paulsson, and G. K. Hansson. 1999. Hydrogen peroxide induces mRNA for tumour necrosis factor-α in human endothelial cells. Free Radical Res. 31:503.
46. Leib, S. L., D. Leppert, J. Clements, and M. G. Tauber. 2000. Matrix metalloproteinases contribute to brain damage in experimental pneumococcal meningitis. Infect. Immun. 68:615.
47. Winkler, F., U. Koedel, S. Kastenbauer, and H. W. Pfister. 2001. Differential expression of nitric oxide synthases in bacterial meningitis: Role of the inducible isoform for blood-brain barrier breakdown. J. Infect. Dis. 183:1749.
48. von Mering, M., A. Wellmer, U. Michel, S. Bunkowski, A. Tlustochowska, W. Bruck, U. Kuhnt, and R. Nau. 2001. Transcriptional regulation of caspases in experimental pneumococcal meningitis. Brain Pathol. 11:282.
49. Christen, S., M. Schaper, J. Lykkesfeldt, C. Siegenthaler, Y. Bifrare, S. Banic, S. L. Leib, and M. G. Tauber. 2001. Oxidative stress in brain during experimental bacterial meningitis: Differential effects of α-phenyl-tert-butyl nitrone and N-acetylcysteine treatment. Free Radical Biol. Med. 31:754.
50. Wellmer, A., J. Gerber, J. Ragheb, G. Zysk, T. Kunst, A. Smirnov, W. Bruck, and R. Nau. 2001. Effect of deficiency of tumor necrosis factor-α or both of its receptors on Streptococcus pneumoniae central nervous system infection and peritonitis. Infect. Immun. 69:6881.
51. Scheld, W. M., V. J. Quagliarello, and A. J. Lesse. 1987. Selected aspects of the pathogenesis and pathophysiology of bacterial meningitis. In Bacterial Meningitis. J. D. Williams and J. Burnie, eds. Academic, London, p. 1.
52. Leib, S. L., and M. G. Täuber. 1999. Pathogenesis of bacterial meningitis. Infect. Dis. Clin. North Am. 13:527.
53. Tuomanen, E., B. Hengstler, O. Zak, and A. Tomasz. 1986. The role of complement in inflammation during experimental pneumococcal meningitis. Microb. Pathog. 1:15.
54. Stahel, P. F., K. Frei, A. Fontana, H. P. Eugster, B. H. Ault, and S. R. Barnum. 1997. Evidence for intrathecal synthesis of alternative pathway complement activation proteins in experimental meningitis. Am. J. Pathol. 151:897.
55. Stahel, P. F., D. Nadal, H. W. Pfister, P. M. Paradisis, and S. R. Barnum. 1997. Complement C3 and factor B cerebrospinal fluid concentrations in bacterial and aseptic meningitis. Lancet 349:1886.
56. Molina, H. 2002. The murine complement regulator Crry: New insights into the immunobiology of complement regulation. Cell. Mol. Life Sci. 59:220.
57. Scheld, W. M., T.-S. Park, R. G. Dacey, H. R. Winn, J. A. Jane, and M. A. Sande. 1979. Clearance of bacteria from cerebrospinal fluid to blood in experimental meningitis. Infect. Immun. 24:102.